Cure8 research brief
If confirmed, an endocytoscopic appearance that corresponds to a specific miRNA and chemokine pattern could help clinicians assess mucosal inflammation during colonoscopy and prioritize biopsies or treatment decisions faster than waiting for pathology.
Gastroenterologists and endoscopists interested in advanced mucosal imaging, clinical researchers studying IBD biomarkers and mucosal immunology, and patients curious about emerging tools to assess mucosal healing.
The researchers compared biopsy miRNA profiles and endocytoscopic (Endocyto) visual grades in patients with UC. Several miRNAs were found to be lower in inflamed tissue; miR-192-5p showed the most consistent decrease in higher endocytoscopic grades and inversely correlated with CXCL2, a pro-inflammatory chemokine.
Endocyto is presented as a tool that might allow clinicians to assess microscopic mucosal inflammation during colonoscopy without waiting for histology; the authors state prospective validation is needed.
This report is an exploratory, cross-sectional analysis linking an imaging classification with tissue biomarkers rather than a trial of a new treatment or diagnostic approval.
This is an exploratory, cross-sectional study using biopsy and imaging correlations; it does not prove that Endocyto can replace histology. The authors call for prospective validation. The article is a journal research report (abstract-level depth provided).
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with IBD have a higher lifetime risk of colorectal cancer; updated UK guidelines give clinicians and patients evidence-based recommendations on when and how to do surveillance colonoscopy to detect precancerous...
Noninvasive monitoring matters for children with UC because endoscopy is burdensome. If ultrasound (and simple measures like bowel wall thickness) can reliably detect moderate-to-severe disease, families may avoid some...
Fecal calprotectin measured by a point‑of‑care CGICA assay showed high accuracy for identifying colorectal inflammation and IBD in patients with chronic diarrhea, which could help avoid some unnecessary colonoscopies...
